Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Amin Al-Ahmad

Clinical Cardiac Electrophysiology Austin, TX Medical Doctor

NPI 1790826923 CMS profile 1012311

3000 N. Ih-35, Suite 700, Ste 110, Austin, TX 78705

Open in the dashboard

General payments

$770,739

1,438 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$610,907 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Amin Al-Ahmad of Austin, TX is reported in the CMS Open Payments database as having received $770,739 across 1,438 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $610,907 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $145,514 196
2024 General $134,088 255
2023 General $62,942 208
2022 General $110,569 269
2021 General $73,220 160
2020 General $133,595 111
2019 General $110,812 239

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Amin Al-Ahmad
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Amin Al-Ahmad were reported at $145,514. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Amin Al-Ahmad Clinical Cardiac Electrophysiology median Middle half National median
2019 $110,812 $2,361 $585–$8,260 $163
2020 $133,595 $993 $247–$4,351 $114
2021 $73,220 $1,185 $326–$4,739 $132
2022 $110,569 $2,073 $554–$6,789 $149
2023 $62,942 $2,568 $759–$8,159 $160
2024 $134,088 $2,557 $703–$7,403 $164
2025 $145,514 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $222,877 358 payments
  2. Boston Scientific Corporation $218,672 202 payments
  3. Ethicon Inc. $115,815 3 payments
  4. Abbott Laboratories $82,596 447 payments
  5. Medtronic Vascular, Inc. $38,852 68 payments
  6. Siemens Medical Solutions USA, Inc. $17,491 28 payments
  7. Cardiva Medical, Inc. $12,859 23 payments
  8. Biosense Webster, Inc. $12,217 167 payments
  9. Haemonetics Corporation $12,140 5 payments
  10. Atricure, Inc. $10,391 17 payments
  11. Other $26,831 120 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $370,598 80 payments
  2. Consulting Fee $175,000 66 payments
  3. Travel and Lodging $112,740 255 payments
  4. Food and Beverage $45,376 1,024 payments
  5. Acquisitions $29,336 3 payments
  6. Current or prospective ownership or investment interest $28,478 2 payments
  7. Honoraria $5,000 2 payments
  8. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $3,000 3 payments
  9. Compensation for serving as faculty or as a speaker for a medical education program $1,050 1 payment
  10. Grant $147 1 payment
  11. Other $14 1 payment
Products named General payments · program years 2019–2025
  1. CLINICAL TRIAL PRODUCT $34,350 14 payments
  2. General Therapies $33,629 7 payments
  3. ENSITE PRECISION $25,834 110 payments
  4. FARAPULSE Farapulse_Rm $23,245 11 payments
  5. General - Therapies $20,167 3 payments
  6. FARAPULSE Farapulse_Ep $17,066 17 payments
  7. WATCHMAN FLX $16,446 5 payments
  8. EnSite Precision Cardiac Mapping System $16,430 50 payments
  9. ACUSON Origin Diagnostic Ultrasound System $14,081 9 payments
  10. Cardiva VASCADE MVP VVCS 6-12F $11,011 18 payments
  11. Other $161,590 857 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

777

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$303,238

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

46.3%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 246 $234,917
Xarelto Rivaroxaban Brand 26 $27,674
Multaq Dronedarone Hcl Brand 27 $26,701
Quinidine Gluconate Generic 12 $4,407
Flecainide Acetate Generic 103 $2,699
Colchicine Generic 104 $2,246
Amiodarone Hcl Generic 36 $1,045
Metoprolol Succinate Generic 84 $943
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 32 $903
Sotalol Sotalol Hcl Brand 29 $624

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 63 billing codes

Paid by Medicare

$260,339

Medicare's payments for the services billed

Medicare patients

562

Average age 76

Services billed

3,486

258 women, 304 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 75%
Ischemic heart disease 52%
Arthritis 50%
Heart failure 42%
Chronic kidney disease 32%
Diabetes 29%
Depression 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
CAMZYOS
$48 — —
MULTAQ
$40 27 —
XARELTO
$29 26 —
VYNDAQEL
$19 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

1,438 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record